Ewer MS - Search Results

1

Cardiac safety of afatinib: a review of data from clinical trials.

Ewer MS, Patel K, O'Brien D, Lorence RM. Ewer MS, et al. Cardiooncology. 2015 Nov 26;1(1):3. doi: 10.1186/s40959-015-0006-7. Cardiooncology. 2015. PMID: 33530147 Free PMC article. Review.

2

An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020.

Fadol AP, Palaskas NL, Ewer MS, Deswal A. Fadol AP, et al. Among authors: ewer ms. Cardiooncology. 2020 Sep 15;6:20. doi: 10.1186/s40959-020-00075-7. eCollection 2020. Cardiooncology. 2020. PMID: 32944289 Free PMC article. Review.

3

TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients.

Monlezun DJ, Hostetter L, Balan P, Palaskas N, Lopez-Mattei J, Cilingiroglu M, Iakobishvili Z, Ewer M, Marmagkiolis K, Iliescu C. Monlezun DJ, et al. Cardiooncology. 2021 Jun 28;7(1):25. doi: 10.1186/s40959-021-00111-0. Cardiooncology. 2021. PMID: 34183072 Free PMC article.

4

Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports.

Ewer MS, Herson J. Ewer MS, et al. Cardiooncology. 2022 Jul 19;8(1):13. doi: 10.1186/s40959-022-00139-w. Cardiooncology. 2022. PMID: 35854393 Free PMC article. Review.

5

Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anticancer Treatments: Do the Data Support the Recommendations?

Ewer MS, Palaskas NL, Herson J. Ewer MS, et al. J Pharmacol Exp Ther. 2023 Aug;386(2):164-168. doi: 10.1124/jpet.122.001555. Epub 2023 Apr 27. J Pharmacol Exp Ther. 2023. PMID: 37105580 Review.

6

Cardiac safety of liposomal anthracyclines.

Ewer MS, Martin FJ, Henderson C, Shapiro CL, Benjamin RS, Gabizon AA. Ewer MS, et al. Semin Oncol. 2004 Dec;31(6 Suppl 13):161-81. doi: 10.1053/j.seminoncol.2004.08.006. Semin Oncol. 2004. PMID: 15717742 Review.

7

Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: a comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac events.

Ewer MS, Suter TM, Lenihan DJ, Niculescu L, Breazna A, Demetri GD, Motzer RJ. Ewer MS, et al. Eur J Cancer. 2014 Aug;50(12):2162-70. doi: 10.1016/j.ejca.2014.05.013. Epub 2014 Jun 12. Eur J Cancer. 2014. PMID: 24930624

8

Cardio-oncology: an ongoing evolution.

Petek BJ, Greenman C, Herrmann J, Ewer MS, Jones RL. Petek BJ, et al. Among authors: ewer ms. Future Oncol. 2015;11(14):2059-66. doi: 10.2217/fon.15.89. Future Oncol. 2015. PMID: 26198836 Review.

9

False Positive Cardiotoxicity Events in Cancer-Related Clinical Trials: Risks Related to Imperfect Noninvasive Parameters.

Ewer MS, Herson J. Ewer MS, et al. Chemotherapy. 2018;63(6):324-329. doi: 10.1159/000495147. Epub 2019 Mar 7. Chemotherapy. 2018. PMID: 30844801 Free article.

10

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.

Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, Pusztai L, Green MC, Arun BK, Giordano SH, Cristofanilli M, Frye DK, Smith TL, Hunt KK, Singletary SE, Sahin AA, Ewer MS, Buchholz TA, Berry D, Hortobagyi GN. Buzdar AU, et al. Among authors: ewer ms. J Clin Oncol. 2005 Jun 1;23(16):3676-85. doi: 10.1200/JCO.2005.07.032. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738535 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page